16-06-2008 MeVis Medical Solutions widening research basis:

Bremen, June 16, 2008. MeVis Medical Solutions AG [ISIN DE000A0LBFE4], a specialist in disease-oriented software solutions for image-based medicine, is widening its research basis.

With the planned conversion of its non-profit subsidiary MeVis Research GmbH into a Fraunhofer Institute, the number of researcher positions will be increased substantially. “As a result, MeVis’ Bremen-based facility will become the largest research center for clinical software applications for image-based medicine in Europe”, says Dr. Carl J.G. Evertsz, President and CEO of MeVis Medical Solutions. The strategic partnership between MeVis Medical Solutions and MeVis Research will be retained even after the latter company’s integration into Fraunhofer Gesellschaft. "MeVis Medical Solutions is planning to additionally strengthen the already close ties with MeVis Research and to extend them to include other innovative areas of research," Evertsz added.

In order for the planned conversion of MeVis Research into a legally independent Fraunhofer Institut to be implemented, Mevis Medical Solutions will initially be required to hand back its 25.1 percent share to the Free Hanseatic City of Bremen. This is planned for the end of June 2008. The transaction does not entail any book losses for MeVis Medical Solutions. Full integration of MeVis Research into Fraunhofer Gesellschaft is expected for the end of 2008. These plans were approved in a decision of the Fraunhofer committee as and are still subject to anti-trust clearance.

MeVis Medical Solutions AG is one of the world’s leading independent producers of software products for medicalimaging technology, particularly digital radiology. Over the past few years, there has been an enormous increase in the complexity and volume of medical image data derived from imaging modalities such as computer tomography (CT) and magnet resonance tomography (MRT). MeVis products analyze and process this data in such a way as to provide medical practitioners with crucial information on the diseases and organs in question for early detection, diagnosis and intervention in the areas of oncology, neurology and surgery. The Company develops its software solutions in close cooperation with medical experts worldwide, and with the world’s leading original equipment manufacturers (OEMs) in the medical technology sector and primarily markets this software via these OEM partnerships.